Organization

The Stem Cell Network North Rhine-Westphalia is a non-profit association founded by 19 scientific institutions in NRW in September 2018. Prior to this, the network had already existed for 16 years under the German name “Kompetenznetzwerk Stammzellforschung NRW”, always supported by the Ministry of Science (currently the Ministry of Culture and Science) of the State of NRW.

The association has three bodies (General Assembly, Representative’s Meeting, and Executive Board), as well as advisory bodies (Board of Trustees and Advisory Board), and an office.

General Assembly

The General Assembly consists of at least one representative of each member. The network currently has 19 members (legal entities), for whom the legal representative (rector or medical director) or a representative appointed by the rector or medical director participates in the meeting of the General Assembly.

Overview of members

Representatives’ Meeting

According to the statutes of the Stem Cell Network NRW, various tasks of the General Assembly were transferred to the Representatives’ Meeting. In contrast to the General Assembly, it does not consist of legal entities, but of natural persons. The General Assembly elects the Representatives’ Meeting. It also determines how many people it should consist of; the figure is currently 20:

Prof. Dr. James Adjaye

Institut für Stammzellforschung und Regenerative Medizin

Universitätsklinikum Düsseldorf

Prof. Dr. James Adjaye

Prof. Dr. Wilhelm Bloch

Abteilung Molekulare und zelluläre Sportmedizin

Deutsche Sporthochschule Köln

Prof. Dr. Wilhelm Bloch

Prof. Dr. Oliver Brüstle

Vorstandsvorsitzender

Institut für Rekonstruktive Neurobiologie

Universitätsklinikum Bonn

Prof. Dr. Oliver Brüstle

Prof. Dr. Frank Dietrich

Institut für Philosophie

Heinrich-Heine-Universität Düsseldorf

Prof. Dr. Frank Dietrich

Prof. Dr. Thomas Dittmar

Institut für Immunologie

Universität Witten/Herdecke

Prof. Dr. Frank Dietrich

Prof. Dr. Andreas Faissner

Fakultät für Biologie und Biotechnologie

Ruhr-Universität Bochum

Prof. Dr. Andreas Faissner

Prof. Jay Gopalakrishnan PhD

Institut für Humangenetik

Heinrich-Heine-Universität Düsseldorf

Prof. Jay Gopalakrishnan PhD

Prof. Dr. Martin Götte

Klinik für Frauenheilkunde und Geburtshilfe

Universitätsklinikum Münster

Prof. Dr. Martin Goette

Prof. Dr. Peter Horn

Sprecher der Vertreterversammlung (Bereich Biomedizin)

Institut für Transfusionsmedizin

Universitätsklinikum Essen

Prof. Dr. Peter Horn

Prof. Dr. Christian Kaltschmidt

Fakultät für Biologie

Universität Bielefeld

Prof. Dr. Christian Kaltschmidt

Prof. Dr. Renate Martinsen

Institut für Politikwissenschaft

Universität Duisburg-Essen

Prof. Dr. Renate Martinsen

Prof. Dr. Dr. Maria Rüger

Klinik und Poliklinik für Neurologie

Universitätsklinikum Köln

Prof. Dr. Dr. Maria Rüger

Prof. Dr. Hans Schöler

Abteilung Zell- und Entwicklungsbiologie

Max-Planck-Institut für molekulare Biomedizin, Münster

Prof. Dr. Hans Schöler

Prof. Dr. Dieter Sturma

Sprecher der Vertreterversammlung (Bereich ELSA)

Institut für Wissenschaft und Ethik

Rheinische Friedrich-Wilhelms-Universität Bonn

Prof. Dr. Dieter Sturma

Prof. Dr. Edda Tobiasch

Institut Rheinbach

Hochschule Bonn-Rhein-Sieg

Prof. Dr. Edda Tobiasch

Prof. Dr. Wolfgang Wagner

Institut für Zellbiologie

Uniklinik RWTH Aachen

Prof. Dr. Wolfgang Wagner

Prof. Dr. Ralf Weberskirch

Fakultät Chemie und Chemische Biologie

Technische Universität Dortmund

Prof. Dr. Ralf Weberskirch

Prof. Dr. Ulrich Willems

Institut für Politikwissenschaft

Westfälische Wilhelms­-Universität Münster

Prof. Dr. Ulrich Willems

Prof. Dr. Christiane Woopen

Forschungsstelle Ethik

Universität zu Köln

Chrisitane Whoopen ©Reiner Zensen

©Reiner Zensen

Prof. Dr. Martin Zenke

Institut für Biomedizinische Technik, Zellbiologie

RWTH Aachen

Prof. Dr. Martin Zenke

Executive Board

The Executive Board conducts the business of the association, including its judicial and extrajudicial representation. It consists of five members. The Representatives’ Meeting elects the Executive Board, which consists of the two spokespersons of the Representatives’ Meeting, one member each from the fields of ethical legal and social aspects (ELSA) and biomedicine, as well as another person from other fields.

Prof. Dr. Oliver Brüstle

Vorstandsvorsitzender

Institut für Rekonstruktive Neurobiologie

Universitätsklinikum Bonn

Prof. Dr. Oliver Brüstle

Prof. Dr. Jens Brüning

Beisitzer

Max-Planck-Institut für Stoffwechselforschung, Köln

Prof. Dr. Jens Brüning

Prof. Dr. Peter Horn

Sprecher der Vertreterversammlung (Bereich Biomedizin)

Institut für Transfusionsmedizin

Universitätsklinikum Essen

Prof. Dr. Peter Horn

Prof. Dr. Bettina Schöne-Seifert

Vertreterin ELSA

Institut für Ethik, Geschichte und Theorie der Medizin

Westfälische Wilhelms-Universität Münster

Prof. Dr. Bettina Schöne-Seifert

Prof. Dr. Dieter Sturma

Sprecher der Vertreterversammlung (Bereich ELSA)

Institut für Wissenschaft und Ethik

Rheinische Friedrich-Wilhelms-Universität Bonn

Prof. Dr. Dieter Sturma

Board of Trustees

The Board of Trustees consists of five members and advises the General Assembly and the other bodies of the association within the scope of their respective responsibilities. It consists of a representative of the State of North Rhine-Westphalia and one representative each in the fields of (i) biomedicine, (ii) ELSA, (iii) industrial applications, and (iv) public research funding. 

Members of the Board of Trustees:

  • Dr. Beate Müller, Ministry of Culture and Science of the State of North Rhine-Westphalia
  • Em. Prof. Dr. med Gerhard Ehninger, TU Dresden
  • Em. Prof. Dr. Dr. h.c. Ludger Honnefelder, University of Bonn
  • Dr. Andreas Bosio, Miltenyi Biotec GmbH
  • Dr. Bülent Genç, Projektträger Jülich (Project Management Organisation)

Advisory Boards

The Advisory Board consists of personalities from public life, who can make contributions due to their own expertise and references to the topic. The members of the Advisory Board are representatives from the fields of science and clinic, politics, regulation and law, religion and belief, patient representatives, and industry.

Office

The office supports the bodies of the association in implementing the stated goals and putting in place the proposed measures. The team consists of the managing director, an advisor for ELSA issues, and a team assistant. 

Office team